MONDAY, April 8, 2024 (HealthDay News) — New research questions the effectiveness of the U.S. Food and Drug Administration’s accelerated drug approval program after finding that many cancer drugs remain unproven five years later. The study, published Sunday in the Journal of the American Medical Association and presented simultaneously atContinue Reading

THURSDAY, April 1, 2024 (HealthDay News) — In a letter sent to teaching hospitals and medical schools across the country, the U.S. Department of Health and Human Services said Monday that written consent must be obtained from patients before performing sensitive procedures such as pelvis and prostate exams. The agencyContinue Reading

THURSDAY, March 28, 2024 (HealthDay News) — Dr. Gary Gibbon didn’t have long to live. A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently destroyed his lungs and caused irreparable damage to his liver. But Gibbon, a 69-year-old resident of Santa Monica, Calif., remainsContinue Reading